These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28864391)

  • 1. Particle interactions of fluticasone propionate and salmeterol xinafoate detected with single particle aerosol mass spectrometry (SPAMS).
    Jetzer MW; Morrical BD; Fergenson DP; Imanidis G
    Int J Pharm; 2017 Oct; 532(1):218-228. PubMed ID: 28864391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products.
    Jetzer MW; Morrical BD; Schneider M; Edge S; Imanidis G
    Int J Pharm; 2018 Mar; 538(1-2):30-39. PubMed ID: 29289516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler.
    Mehta R; Riddell K; Gupta A; Louey MD; Chan RH
    Clin Drug Investig; 2015 May; 35(5):319-26. PubMed ID: 25805608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.
    New A; Prime D; Zomer S; Elder D; Donovan R; Freney E
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3873-82. PubMed ID: 19003851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
    Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Shepherd T; Kennett M; Cooper A; Parkinson A
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):154-165. PubMed ID: 34726509
    [No Abstract]   [Full Text] [Related]  

  • 8. The on-line analysis of aerosol-delivered pharmaceuticals via single particle aerosol mass spectrometry.
    Morrical BD; Balaxi M; Fergenson D
    Int J Pharm; 2015 Jul; 489(1-2):11-7. PubMed ID: 25891255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.
    Theophilus A; Moore A; Prime D; Rossomanno S; Whitcher B; Chrystyn H
    Int J Pharm; 2006 Apr; 313(1-2):14-22. PubMed ID: 16516417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
    Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
    Nugent C; Yiu G; Song S; Caracta C
    J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial.
    Jõgi R; Lähelmä S; Vahteristo M; Happonen A; Haikarainen J
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):88-98. PubMed ID: 30300557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution of fine particle fraction from truncated Anderson cascade impactor with an enhancer cell.
    Tay JYS; Liew CV; Heng PWS
    Int J Pharm; 2018 Jul; 545(1-2):45-50. PubMed ID: 29689370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
    Hojo M; Shirai T; Hirashima J; Iikura M; Sugiyama H
    Pulm Pharmacol Ther; 2016 Apr; 37():43-8. PubMed ID: 26898348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick
    Paik J; Scott LJ; Pleasants RA
    Clin Drug Investig; 2018 May; 38(5):463-473. PubMed ID: 29582249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
    Harrison LI; Novak CC; Needham MJ; Ratner P
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantitative determinations of fluticasone propionate and salmeterol xinafote in diskus inhalers.
    Duran A; Dogan HN; Ulgen M
    Drug Metab Lett; 2014; 8(1):31-5. PubMed ID: 25313021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma.
    Miller DS; Yiu G; Hellriegel ET; Steinfeld J
    Allergy Asthma Proc; 2016 Jul; 37(4):291-301. PubMed ID: 27216137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.